Document is current
Any future updates will be listed below
-
Authors
Doshi, Pranav
Donovan, Anna K.
Kim, Erin J.
Moretti, Meghan
Chan, Stephen Y.
Veldkamp, Peter J.
Schikowski, Erin M. https://orcid.org/0000-0002-5819-7796
- License Information
-
More Information
Article History
Received: 5 June 2024
Accepted: 29 October 2024
First Online: 18 November 2024
Declarations:
:
: S.Y.C. is a founder and Chair of the Board of Directors of the Addis Clinic. S.Y.C. has served as a consultant for Merck and United Therapeutics. S.Y.C. is a director, officer, and shareholder in Synhale Therapeutics. S.Y.C. has held research grants from United Therapeutics and Bayer. S.Y.C. has filed patent applications regarding the targeting of metabolism in pulmonary hypertension (Patent: Compositions and Methods for Treating Pulmonary Vascular Disease, US10925869B2). The other authors declare no competing interests. All remaining authors have no conflicts of interest to disclose.
Free to read: This content has been made available to all.
